-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-executive-sum.pdf
January 01, 2024 - event outcomes (psychosis, cannabis use disorder, cognitive
deficits) and outcomes on the impact on opioid … Duration,
Weeks (Range)
12 to 208 52 26 24 24
Abbreviations: CBD = cannabidiol; LAO = long-acting opioid … reporting of important outcomes
such as dosage, pain response, overall function or disability, effect on opioid … J Opioid
Manag. 2009 Nov-Dec;5(6):341-57. doi:
10.5055/jom.2009.0034. PMID: 20073408.
2.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/outcomes-dental-services-rapid-research.pdf
May 01, 2025 - examples of FDA-approved medications for SUD include methadone, buprenorphine, and
naltrexone for opioid … For instance, oral
prescription methadone, a common treatment for opioid use disorder, contains high … no mention of
dental care
Health Resources and
Services Administration
Caring for Women with Opioid … American Society of
Addiction Medicine
ASAM National Practice Guideline
for the Treatment of Opioid … dental care
Substance Abuse and
Mental Health Services
Administration
Federal Guidelines for Opioid
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/practical-considerations.pdf
March 01, 2022 - received particular
scrutiny due to their addiction and overdose potential,8 especially given the ongoing opioid … Since there was
no other evidence on the outcome of interest (effect on opioid use) for the type of … Opioid
treatments for chronic pain. Rockville, MD;
2020.
8. U.S. … Reducing the risks of
relief--the CDC opioid-prescribing
guideline.
-
effectivehealthcare.ahrq.gov/products/emt-naloxon/research-protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-emergency_executive.pdf
November 01, 2012 - 1
Comparative Effectiveness Review
Number 84
Acute Migraine Treatment
in Emergency Settings
Executive Summary
Introduction
Migraine is a chronic neurovascular
disorder characterized by dysfunction
of the central and peripheral nervous
systems and intracranial vasculature.1
Acute exacerbations of episodic …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2025-surv-rep-update-executive-sum.pdf
January 01, 2025 - Duration,
Weeks (Range)
12 to 208 52 26 24 24
Abbreviations: CBD = cannabidiol; LAO = long acting opioid … reporting of important outcomes
such as dosage, pain response, overall function or disability, effect on opioid … J Opioid
Manag. 2009 Nov-Dec;5(6):341-57. doi:
10.5055/jom.2009.0034. PMID: 20073408.
8.
-
effectivehealthcare.ahrq.gov/sites/default/files/back-pain-treatment_disposition-comments.pdf
February 29, 2016 - Given the harms
that are being identified with the use of
opioid agents, this seems like a glaring … We
cited a recent AHRQ-funded
review on long-term opioid therapy
that we conducted for an NIH
Pathways … Opioid analgesics
such as oxycodone hydrocodone and
methadone were involved in about 3 of
every 4 … pharmaceutical overdose deaths
16651 confirming the predominant role
opioid analgesics play in drug … overdose
deaths. 6I understand that the CDCs
posting of opioid deaths in 2010 an
observational study
-
effectivehealthcare.ahrq.gov/sites/default/files/noninvasive-nonpharm-pain-summary.pdf
April 01, 2020 - use of nonopioid treatment over opioid
therapy. … In our concurrent
review on opioid medications for chronic pain
management, opioids were associated … Recent guidelines from the CDC7 in the
United States and the Canadian Guidelines
for Opioid Use in … The effectiveness
and risks of long-term opioid therapy for chronic pain:
a systematic review for a … The President’s Commission on Combating Drug
Addiction and the Opioid Crisis.
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetic-neuropathy-disposition-170707.pdf
March 24, 2017 - manufacturer itself:
Coffey et al, Mortality associated with implantation
and management of intrathecal opioid … TEP #2 Results –
KQ2
I don’t think a summary statement of opioid efficacy
should be made based on … results from a single opioid,
i.e., oxycodone.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetic-neuropathy-disposition-170707.pdf
March 24, 2017 - manufacturer itself:
Coffey et al, Mortality associated with implantation
and management of intrathecal opioid … TEP #2 Results –
KQ2
I don’t think a summary statement of opioid efficacy
should be made based on … results from a single opioid,
i.e., oxycodone.
-
effectivehealthcare.ahrq.gov/products/collections/improving-pain-management
-
effectivehealthcare.ahrq.gov/sites/default/files/hip-fracture-pain_surveillance.pdf
July 08, 2015 - Opioid analgesics and the
risk of fractures in older adults with arthritis. … Opioid dose (P > .59)
on Postoperative Days 1 and 2 was not predictive of incident delirium. … Opioid analgesia was
provided in response to pain at rest to achieve scores of 3 or less. … Opioid dose (P > .59) on Postoperative Days 1 and 2
was not predictive of incident delirium. … Opioid dose (P > .59)
on Postoperative Days 1 and
2 was not predictive of
incident delirium.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/epc-health-care-practice-delivery.pdf
November 01, 2022 - health-related topics, including—
◆ Clinical areas (e.g., treatments for depression, management of opioid
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0651-131114.pdf
June 20, 2013 - Topic 0552 Low Back Pain NSD FINAL SJ
Diagnosis and Treatment of Low Back Pain
Nomination Summary Document
Results of Topic Selection Process & Next Steps
The topic, Dia…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-254-rural-telehealth-executive-summary.pdf
December 01, 2022 - populations experience higher mortality2-5 and morbidity from a wide range of
conditions including substance/opioid … Understanding the rural-urban differences in
nonmedical prescription opioid use and
abuse in the United … Examining
rural/urban differences in prescription opioid
misuse among US adolescents.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix-E-Evidence-Tables-E1-E4_0.xlsx
May 29, 2025 - Race, Other % Pain Duration Measure
(Mean, Median) Pain Duration, months Psychiatric Comorbidity % Opioid … Previous treatment with weak opioid: 42 vs. 38
Previous treatment with strong opioid: 19 vs. 11 96 71 … : 4% (7/167) vs. 4% (7/172)
Other opioid: 20% (33/167) vs. 18% (31/172) 339 339 THC 2.7 mg/CBD 2.5 mg … : 9 vs. 13
Opioid: 2 vs. 3
Strong opioid: 3 vs. 0 66 66 THC 2.7 mg/CBD 2.5 mg per 100 mcl oromucosal … Use (Mean Daily Dose [MDD]) Opioid Equivalents Assessment Time (Weeks) Variance Type for Opioid Use
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1512.pdf
December 01, 2015 - Evzio for emergency treatment of opioid overdose by nonclinicians Prior high impact topic; archived due … Healthcare Horizon Scanning System include two intranasal naloxone spray products for treating
opioid … high-impact topic from the June 2015 report has been archived:
Evzio for emergency treatment of opioid … overdose by nonclinicians: Opioid overdoses
are a potentially fatal consequence of prescription or … illicit opioid abuse.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0477_11-01-2011.pdf
January 01, 2011 - inhibitors (SSRIs) such as fluoxetine);
muscle relaxants (e.g., cyclobenzaprine); simple analgesics; opioid
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f1-f4-tables-surveillance-report-2_0_0.xlsx
May 29, 2025 - Race, Other % Pain Duration Measure
(Mean, Median) Pain Duration, Months Psychiatric Comorbidity % Opioid … Previous treatment with weak opioid: 42 vs. 38
Previous treatment with strong opioid: 19 vs. 11 96 71 … : 4% (7/167) vs. 4% (7/172)
Other opioid: 20% (33/167) vs. 18% (31/172) 339 339 THC 2.7 mg/CBD 2.5 mg … : 9 vs. 13
Opioid: 2 vs. 3
Strong opioid: 3 vs. 0 66 66 THC 2.7 mg/CBD 2.5 mg per 100 mcl oromucosal … Use (Mean Daily Dose [MDD]) Opioid Equivalents Assessment Time (Weeks) Variance Type for Opioid Use
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
January 01, 2015 - The cost of one care process innovation, the Lazarus Opioid Overdose Prevention and
Treatment Program … Community-Based
Opioid Overdose
Prevention Program
(Project Lazarus)
Initiated in Wilkes County, … Evzio for Emergency
Treatment of Opioid
Overdose by
Nonclinicians
Evzio™ (kaléo, Inc., Richmond, … Overdose by
Nonclinicians Drug/device combo $186,400,000 $39,100,000
Lazarus Opioid Overdose … Naloxone Evzio, Auto-
Injector for Treatment
of Opioid Overdose by
Non-Clinicians
FDA approved a